| Date | Title | Description |
| 05.04.2026 | University Of Colorado Boulder: Partnership With Techstars To Accelerate Startup Ecosystem | The University of Colorado Boulder and Techstars have announced a strategic partnership to expand opportunities for founders and strengthen Colorado’s innovation economy.
The collaboration links CU Boulder’s entrepreneurship programs and st... |
| 12.01.2026 | Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team | T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., ... |
| 25.06.2025 | Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy | Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach
Positions Illumina to achieve growth in a large, expanding market
Illumina and SomaLogic have partnered in proteo... |
| 23.06.2025 | Federal Reserve’s Bowman says rate cut should be on table in July | Related Articles
Illumina buying Boulder’s SomaLogic for more than $350M
Boulder boasts nation’s best restaurant in Frasca
Compass files lawsuit against Zillow over private home listings policy
Why target-date funds are great IRA investment... |
| 23.06.2025 | Illumina buying Boulder’s SomaLogic for more than $350M | Less than two years after Boulder-based biotech firm SomaLogic Inc. merged with Standard BioTools Inc. (Nasdaq: LAB), Illumina Inc. (NASDAQ: ILMN) has inked a deal to absorb SomaLogic’s business in an acquisition worth as much as $425 milli... |
| 20.04.2023 | SomaLogic to Announce First Quarter 2023 Financial Results on May 11, 2023 | BOULDER, Colo., April 20, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the first quarter 2023 after market close on Thursday, May 11, 2023. Management... |
| 13.06.2022 | SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics | BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-gene... |
| 12.01.2022 | OncoHost Announces Interim Results from PROPHETIC Trial, Multicenter Assessment of NSCLC Patient Response to Immunotherapy | BINYAMINA, Israel, Jan. 12, 2022 /PRNewswire/ -- OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced results from its ongoing multicenter clinical trial, PROPHETIC. These... |
| 12.01.2022 | OncoHost Announces Interim Results from PROPHETIC Trial, Multicenter Assessment of NSCLC Patient Response to Immunotherapy | BINYAMINA, Israel, Jan. 12, 2022 /PRNewswire/ -- OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced results from its ongoing multicenter clinical trial, PROPHETIC. These... |
| 01.11.2021 | SomaLogic announces strategic collaboration with University Hospitals Cleveland Medical Center to treat diabetic patients at high risk of cardiovascular disease | BOULDER, Colo., Nov. 01, 2021 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with one of the nation’s leading academic medical centers, University Hospi... |
| 06.09.2021 | SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker SLGC | SomaLogic, Inc., a leader in AI-data driven proteomics technology, announced that it has completed its business combination with CM Life Sciences II, Inc., a special purpose acquisition company sponsored by affiliates of leading healthcare ... |
| 31.08.2021 | SomaLogic expands leadership team with new positions to drive commercial success | NEW YORK and BOULDER, Colo., Aug. 31, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, today announced the recent appointments of Todd Johnson as Executive Vice Pr... |
| 03.08.2021 | SomaLogic Announces Appointment Of Shaun Blakeman As Chief Financial Officer | CM Life Sciences II and SomaLogic, a leader in AI-data driven proteomics technology, announced the appointment of Shaun Blakeman as the company’s Chief Financial Officer.
SysAdmin Appreciation Day: Top Industry Leaders Share their Insights ... |
| 29.03.2021 | SomaLogic To Go Public Via SPAC | SomaLogic, a Boulder, CO-based global leader in proteomics technology, and CM Life Sciences II (NASDAQ: CMIIU), a special purpose acquisition company, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, entered into a d... |
| 04.01.2021 | SomaLogic Adds $81 Million To Current Funding Round, Bringing Total To $214 Million | SomaLogic — a leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics — announced that it added $81 million to its current funding round
SomaLogic — a leader in proteomic discovery and appli... |
| 24.12.2020 | SomaLogic Raises Additional $81M to Series A Financing Totaling $214M | SomaLogic, Inc., a Boulder, CO-based global developer of proteomic discovery and applications for biomedical discovery and clinical diagnostics, added $81M to Series A raise which now totals $214M.
In this second close, additional financial... |
| 23.12.2020 | SomaLogic Adds $81 Million to Series A Financing Totaling $214 Million | SomaLogic, global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced that it added $81 Million to its current funding round with investments from a number of additional inves... |
| 23.12.2020 | Oscar Raises $140M, Babylon Health, Modern Health, Diameter Health, Curai Health, Others Recent Digital Health Funding | Oscar Raises $140M, Confidentiality Files for IPO
Oscar, the first health insurance company built on a full stack technology platform raises $140M in funding led by Tiger Global Management, LLC, with participation from Dragoneer, Baillie Gi... |
| 22.12.2020 | SomaLogic Adds $81M to Series A Financing Totaling $214M | BOULDER, Colo., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that it added $81M to its current funding r... |
| 25.11.2020 | Boulder’s SomaLogic raises $121M in Series A round, setting record for 2020 fundraising in region | Blood protein testmaker SomaLogic Inc. has secured $121 million in its Series A financing round, making it the largest venture-capital round in the region so far this year.
In a statement, the Boulder company said the round was led by New Y... |
| 25.11.2020 | SomaLogic Closes $121M Series A Financing Led by Casdin Capital | BOULDER, Colo., Nov. 25, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that the Company has successfully closed an... |
| 04.09.2019 | SomaLogic launches its firsts SomaSignal tests in Colorado | Boulder’s SomaLogic on Wednesday launched its first SomaSignal tests that can provide precise medical information about a person’s cardiometabolic health.
The laboratory-developed tests measure thousands of proteins in a blood sample.The me... |
| 05.01.2018 | Term Sheet — Friday, January 5 | THE BILLIONAIRE CLUB
Happy Friday, Term Sheet readers!
Paid Content Securing the enterprise without boundaries From ExtraHop
Things changed this week. Kalanick plans to sell 29% of his stake in Uber. This means the ex-CEO will sell equity w... |
| 04.01.2018 | Madryn Joins $200M Funding for SomaLogic | SomaLogic announced today that it has capped its $200 million funding round, anchored by iCarbonX with substantial investments from Nan Fung Life Sciences and Madryn Asset Management. The successful round will accelerate SomaLogic’s goal of... |
| 04.01.2018 | SomaLogic Closes $200M Financing Round | SomaLogic, a Boulder, CO-based provider of a platform that delivers actionable health-management insights for individuals to optimize their personal health and wellness, closed a $200m funding round.
The round was anchored by iCarbonX with ... |
| 06.01.2017 | $100M PatientsLikeMe-iCarbonX deal highlights huge day in digital health investment | PatientsLikeMe is getting a huge cash infusion while also expanding its genomics capabilities.
The patient social network on Thursday announced at least $100 million in new investment, courtesy of a partnership with Chinese startup iCarbonX... |
| 24.06.2016 | Proteomics shows promise for assessing risk of heart attacks and strokes | Proteomics may be more accurate than assessing those traditional risk factors because “proteins are one step closer to the disease itself,” explained Dr. Peter Ganz, the study’s principal investigator and a professor of medicine at the Univ... |
| 01.03.2016 | SomaLogic Raises $60.5M |
BOULDER, CO, SomaLogic and Visium Healthcare Partners, LP today announced that SomaLogic will receive up to $60.5 million through a combination of debt and equity financing from Visium.
>> Click here for more funding data on SomaLo... |
| 01.03.2016 | SomaLogic to Raise up to $60.5M in Debt and Equity Financing | SomaLogic, Inc., a Boulder, CO-based medical diagnostic technology company, is to raise up to $60.5m in debt and equity financing.
Visium Healthcare Partners will provide the funds.
The company intends to use the funds for continued growth,... |
| 10.11.2014 | Right after Novartis takes stake in proteomics company, it raises $16.5M | SomaLogic has outlined its proteomics applications in a number of spaces:
Though the privately held SomaLogic has been around more than a decade, it’s raised $46.5 million since 2010.
Promoted
This Patient Experience Checklist Is Your Key T... |
| 30.08.2013 | SomaLogic Raises $10M in Funding | SomaLogic, a Bolder, CO-based protein biomarker discovery and clinical diagnostics company, raised $10m in funding.
A filing with the S.E.C. lists a single (undisclosed) investor.
Larry Gold, Ph.D., Chairman and CEO, SomaLogic develops nove... |
| 23.08.2013 | Mile High Roundup: Spaceships, SomaLogic Stays Silent, and SanDisk | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Welcome to the Mile High Roundup, a look at some of the interesting things that have happened over the past two weeks in the tech scene in Boulder, Denver, and around Colorado... |
| - | Proteomics shows promise for assessing risk of heart attacks and strokes | The promise of proteomics—measuring protein levels—as a tool for assessing risk of heart attacks and strokes was highlighted in a new study in the Journal of the American Medical Association.
In this study, published this week, researchers ... |
| - | Right after Novartis takes stake in proteomics company, it raises $16.5M | Just a few weeks after Novartis announced it’s taken an ownership stake in Colorado’s SomaLogic, the proteomics company has raised $16.5 million, according to a regulatory filing.
Although SomaLogic’s keeping quiet on who’s invested and wha... |
| - | $100M PatientsLikeMe-iCarbonX deal highlights huge day in digital health investment | PatientsLikeMe is getting a huge cash infusion while also expanding its genomics capabilities.
The patient social network on Thursday announced at least $100 million in new investment, courtesy of a partnership with Chinese startup iCarbonX... |
| - | Real-world data and Covid-19: Extending the measurable phenotype | Real-world evidence is only as good as the real-world data from which it is derived. While real-world data has traditionally included electronic health records, registries, claims and billing info, and self-reported patient data, the FDA an... |
